Viktor Magdolen

Viktor Magdolen

UNVERIFIED PROFILE

Are you Viktor Magdolen?   Register this Author

Register author
Viktor Magdolen

Viktor Magdolen

Publications by authors named "Viktor Magdolen"

Are you Viktor Magdolen?   Register this Author

100Publications

1473Reads

47Profile Views

Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients.

Mol Med 2020 Feb 7;26(1):19. Epub 2020 Feb 7.

Clinical Research Unit, Department of Obstetrics and Gynecology, Technical University of Munich, Ismaninger Str. 22, 81576, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s10020-020-0145-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006133PMC
February 2020

Surface loops of trypsin-like serine proteases as determinants of function.

Biochimie 2019 Nov 7;166:52-76. Epub 2019 Sep 7.

Clinical Research Unit, Department of Obstetrics and Gynecology, School of Medicine, Technical University of Munich, Ismaninger Strasse 22, 81675, München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biochi.2019.09.004DOI Listing
November 2019

Proteolytic chemokine cleavage as a regulator of lymphocytic infiltration in solid tumors.

Cancer Metastasis Rev 2019 09;38(3):417-430

Clinical Research Unit, Department of Obstetrics and Gynecology, Technical University of Munich, Ismaninger Straße 22, D-81675, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10555-019-09807-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890590PMC
September 2019

Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PET.

Transl Neurodegener 2019 27;8:25. Epub 2019 Aug 27.

1Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Ismaninger Str. 22, 81675 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40035-019-0168-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712703PMC
August 2019

Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome.

Mol Cell Proteomics 2019 05 31;18(5):818-836. Epub 2019 Jan 31.

From the ‡Queensland University of Technology (QUT), Institute of Health and Biomedical Innovation (IHBI) and School of Biomedical Sciences at the Translational Research Institute, 37 Kent Street, Woolloongabba, Queensland, 4102, Australia;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/mcp.RA118.001304DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495248PMC
May 2019

Kallikrein-related peptidase 7 overexpression in melanoma cells modulates cell adhesion leading to a malignant phenotype.

Biol Chem 2018 09;399(9):1099-1105

Institut National de la Santé et de la Recherche Médicale (INSERM) U976, Hôpital Saint Louis, 1 Avenue Claude Vellefaux, F-75010 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/hsz-2017-0339DOI Listing
September 2018

Insights into the activity control of the kallikrein-related peptidase 6: small-molecule modulators and allosterism.

Biol Chem 2018 09;399(9):1073-1078

Sorbonne University, Faculty of Sciences and Engineering, IBPS, UMR 8256 CNRS-UPMC, ERL INSERM U1164, Biological Adaptation and Ageing, F-75252 Paris, France.

View Article

Download full-text PDF

Source
http://www.degruyter.com/view/j/bchm.2018.399.issue-9/hsz-20
Publisher Site
http://dx.doi.org/10.1515/hsz-2017-0336DOI Listing
September 2018

Activation and activity of glycosylated KLKs 3, 4 and 11.

Biol Chem 2018 09;399(9):1009-1022

Division of Structural Biology, Department of Biosciences, University of Salzburg, Billrothstrasse 11, A-5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/hsz-2018-0148DOI Listing
September 2018

Kallikrein-related peptidases are activators of the CC chemokine CCL14.

Eur J Immunol 2018 09 22;48(9):1592-1594. Epub 2018 Aug 22.

Anhalt University of Applied Sciences, Molecular Biotechnology, Köthen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201747452DOI Listing
September 2018

Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer.

Expert Opin Ther Targets 2018 09 6;22(9):745-763. Epub 2018 Sep 6.

d Department of Obstetrics and Gynecology , Technical University of Munich , Munich , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14728222.2018.1512587DOI Listing
September 2018

The Predictive Value of DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges.

Dis Markers 2017 12;2017:4934608. Epub 2017 Sep 12.

Department of Obstetrics and Gynecology, Clinical Research Unit, Klinikum rechts der Isar, Technische Universität München, Ismaningerstr. 22, 81675 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/4934608DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613359PMC
June 2018

Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients' prognosis.

J Cancer Res Clin Oncol 2018 Jun 15;144(6):1109-1118. Epub 2018 Mar 15.

Clinical Research Unit, Department of Obstetrics and Gynecology, Technische Universität München, Ismaninger Str. 22, 81675, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-018-2623-7DOI Listing
June 2018

Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach.

J Proteomics 2018 06 22;182:12-20. Epub 2018 Apr 22.

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada; Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada; Department of Clinical Biochemistry, University Health Network, Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jprot.2018.04.027DOI Listing
June 2018

Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases.

Am J Cancer Res 2017 1;7(11):2257-2274. Epub 2017 Nov 1.

Mater Research Institute-University of Queensland, Translational Research InstituteWoolloongabba, Queensland 4102, Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714754PMC
November 2017

Preclinical evaluation of [ In]MICA-401, an activity-based probe for SPECT imaging of in vivo uPA activity.

Contrast Media Mol Imaging 2016 11 24;11(6):448-458. Epub 2016 Aug 24.

Molecular Imaging Center Antwerp, University of Antwerp, Universiteitsplein 1, B-2610, Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cmmi.1706DOI Listing
November 2016

The solution structure of the kallikrein-related peptidases inhibitor SPINK6.

Biochem Biophys Res Commun 2016 Feb 30;471(1):103-8. Epub 2016 Jan 30.

Institute of Biochemistry, Christian-Albrechts-University, Olshausenstr. 40, 24098 Kiel, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2016.01.172DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553623PMC
February 2016

STIM1/ORAI1-mediated Ca2+ Influx Regulates Enolase-1 Exteriorization.

J Biol Chem 2015 May 24;290(19):11983-99. Epub 2015 Mar 24.

From the Department of Biochemistry, University of Giessen Lung Center, 35392 Giessen, Germany,

View Article

Download full-text PDF

Source
http://www.jbc.org/lookup/doi/10.1074/jbc.M114.598425
Publisher Site
http://dx.doi.org/10.1074/jbc.M114.598425DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424336PMC
May 2015

Structure-function analyses of human kallikrein-related peptidase 2 establish the 99-loop as master regulator of activity.

J Biol Chem 2014 Dec 16;289(49):34267-83. Epub 2014 Oct 16.

From the Division of Structural Biology, Department of Molecular Biology, University of Salzburg, A-5020 Salzburg, Austria,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M114.598201DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256358PMC
December 2014

Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers.

Crit Rev Clin Lab Sci 2014 Apr 3;51(2):63-84. Epub 2014 Feb 3.

Klinische Forschergruppe der Frauenklinik der Technischen Universität München, Klinikum rechts der Isar , Munich , Germany .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10408363.2013.865701DOI Listing
April 2014

Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells.

Mol Oncol 2014 Feb 1;8(1):68-82. Epub 2013 Oct 1.

Institute of Molecular Medicine and Cell Research, University of Freiburg, D-79104 Freiburg, Germany; BIOSS Centre for Biological Signaling Studies, University of Freiburg, D-79104 Freiburg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2013.09.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528505PMC
February 2014

Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies.

Radiol Oncol 2013 8;47(4):319-29. Epub 2013 Oct 8.

Clinical Research Unit, Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2478/raon-2013-0053DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814276PMC
December 2013

A bioengineered 3D ovarian cancer model for the assessment of peptidase-mediated enhancement of spheroid growth and intraperitoneal spread.

Biomaterials 2013 Oct 1;34(30):7389-400. Epub 2013 Jul 1.

Faculty of Health, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, Queensland 4059, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biomaterials.2013.06.009DOI Listing
October 2013

Impact of expression of the uPA system in sarcomas.

Biomark Med 2013 Jun;7(3):473-80

Clinic of Urology, Division of Molecular Urology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/bmm.12.105DOI Listing
June 2013

Combined expression of KLK4, KLK5, KLK6, and KLK7 by ovarian cancer cells leads to decreased adhesion and paclitaxel-induced chemoresistance.

Gynecol Oncol 2012 Dec 8;127(3):569-78. Epub 2012 Sep 8.

Cancer Program, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, 60 Musk Avenue, Kelvin Grove, Brisbane, Queensland 4059, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.09.001DOI Listing
December 2012

Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cells.

Mol Cancer 2012 Aug 24;11:62. Epub 2012 Aug 24.

Clinical Research Unit, Department of Obstetrics and Gynecology, Technical University of Munich, Ismaninger Str, 22, Munich 81675, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-11-62DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499445PMC
August 2012

Overexpression of the urokinase receptor mRNA splice variant uPAR-del4/5 affects tumor-associated processes of breast cancer cells in vitro and in vivo.

Breast Cancer Res Treat 2011 Jun 16;127(3):649-57. Epub 2010 Jul 16.

Clinical Research Unit, Department of Obstetrics and Gynecology, Technical University Munich, Ismaninger Str. 22, 81675 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-1042-5DOI Listing
June 2011

Gene expression analysis of HUVEC in response to TF-binding.

Thromb Res 2011 Mar 24;127(3):259-63. Epub 2010 Dec 24.

Institute of Pathology, Technical University of Dresden, D-01307 Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2010.11.024DOI Listing
March 2011

Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).

Biochimie 2010 Nov 6;92(11):1546-67. Epub 2010 Jul 6.

Division of Structural Biology, Department of Molecular Biology, University of Salzburg, Billrothstrasse 11, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biochi.2010.06.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014083PMC
November 2010

Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.

Expert Rev Mol Diagn 2010 Oct;10(7):947-62

Klinikum rechts der Isar of the Technische Universität München, Ismaninger Strasse 22, D-81675 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erm.10.73DOI Listing
October 2010

Interdependence of kallikrein-related peptidases in proteolytic networks.

Biol Chem 2010 May;391(5):581-7

Department of Obstetrics and Gynecology, Technical University of Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/BC.2010.055DOI Listing
May 2010

Activation of human pro-urokinase by unrelated proteases secreted by Pseudomonas aeruginosa.

Biochem J 2010 May 27;428(3):473-82. Epub 2010 May 27.

Department of Obstetrics and Gynecology, Technical University of Munich, Ismaninger Strasse 22, D-81675 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/BJ20091806DOI Listing
May 2010

Using kallikrein-related peptidases (KLK) as novel cancer biomarkers.

Thromb Haemost 2009 Feb;101(2):222-4

View Article

Download full-text PDF

Source
February 2009

Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects.

Breast Care (Basel) 2008;3(s2):3-10. Epub 2008 Oct 15.

Clinical Research Unit, Department of Obstetrics and Gynecology Klinikum rechts der Isar, Technical University of Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000151737DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930995PMC
October 2008

Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7.

Biol Chem 2008 Jun;389(6):623-32

Max-Planck-Institut für Biochemie, Proteinase Research Group, Am Klopferspitz 18, D-82152 Martinsried, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/BC.2008.075DOI Listing
June 2008

The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin.

Biochem J 2008 Feb;410(1):157-65

Department of Obstetrics and Gynecology, Technical University of Munich, Ismaninger Str. 22, D-81675 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/BJ20070650DOI Listing
February 2008

Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in alpha-emitter therapy for disseminated ovarian cancer.

Eur J Nucl Med Mol Imaging 2008 Jan 22;35(1):53-64. Epub 2007 Sep 22.

Department Chemie, Lehrstuhl II für Organische Chemie, Technische Universität München, Lichtenbergstrasse 4, 85747, Garching, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-007-0582-3DOI Listing
January 2008

Structural basis of the zinc inhibition of human tissue kallikrein 5.

J Mol Biol 2007 Nov 24;373(4):1017-31. Epub 2007 Aug 24.

Max-Planck-Institut für Biochemie, Proteinase Research Group, Am Klopferspitz 18, 82152 Martinsried, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmb.2007.08.042DOI Listing
November 2007

Chymotryptic specificity determinants in the 1.0 A structure of the zinc-inhibited human tissue kallikrein 7.

Proc Natl Acad Sci U S A 2007 Oct 1;104(41):16086-91. Epub 2007 Oct 1.

Max-Planck-Institut für Biochemie, Proteinase Research Group, Am Klopferspitz 18, 82152 Martinsried, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0707811104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2042166PMC
October 2007

Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site.

J Mol Biol 2006 Oct 3;362(5):1094-107. Epub 2006 Aug 3.

Max-Planck-Institut für Biochemie, Proteinase Research Group, Am Klopferspitz 18, 82152 Martinsried, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmb.2006.08.003DOI Listing
October 2006

Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences.

J Biol Chem 2006 Sep 1;281(35):25678-88. Epub 2006 Jun 1.

Max-Planck-Institut für Biochemie, Proteinase Research Group, Am Klopferspitz 18, D-82152 Martinsried, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M602372200DOI Listing
September 2006

Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma.

Biol Chem 2006 Aug;387(8):1121-8

Clinical Research Unit, Department of Obstetrics and Gynecology, Technical University of Munich, D-81675 Munich, Germany, and Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada.

View Article

Download full-text PDF

Source
https://www.degruyter.com/view/j/bchm.2006.387.issue-8/bc.20
Publisher Site
http://dx.doi.org/10.1515/BC.2006.138DOI Listing
August 2006

Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells.

Biol Chem 2006 Jun;387(6):807-11

Clinical Research Unit, Department of Obstetrics and Gynecology, Technical University of Munich, D-81675 Munich, Germany, and G. Papanicolaou Research Center of Oncology, Saint Savas Hospital, GR-11522 Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/BC.2006.102DOI Listing
June 2006

Methods to analyze the effects of the urokinase system on cancer cell adhesion, proliferation, migration, and signal transduction events.

Methods Mol Med 2006 ;120:427-40

Department of Obstetrics and Gynaecology, Technical University of Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/1-59259-969-9:427DOI Listing
March 2006

Interplay of human tissue kallikrein 4 (hK4) with the plasminogen activation system: hK4 regulates the structure and functions of the urokinase-type plasminogen activator receptor (uPAR).

Biol Chem 2006 Feb;387(2):217-22

Unité de Défense Innée et Inflammation/INSERM E0336, Département de Médecine Moléculaire, Institut Pasteur, F-75015 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/BC.2006.029DOI Listing
February 2006

Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer.

Eur J Cancer 2005 Nov 26;41(17):2760-8. Epub 2005 Oct 26.

Institute of Pathology, Technical University Dresden, Fetscherstr. 74, D-01307 Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2005.09.002DOI Listing
November 2005

Clinical course of sarcoidosis in dependence on HLA-DRB1 allele frequencies, inflammatory markers, and the presence of M. tuberculosis DNA fragments.

Sarcoidosis Vasc Diffuse Lung Dis 2005 Mar;22(1):66-74

Institut für Pathologie, Technische Universität Dresden, D-01307 Dresden, Germany.

View Article

Download full-text PDF

Source
March 2005

Non-muscle alpha-actinin-4 interacts with plasminogen activator inhibitor type-1 (PAI-1).

Biol Chem 2004 Sep;385(9):801-8

Klinische Forschergruppe der Frauenklinik der Technischen Universität München, Klinikum rechts der Isar, Ismaninger str. 22, D-81675 München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/BC.2004.105DOI Listing
September 2004

Proteolytic regulation of the urokinase receptor/CD87 on monocytic cells by neutrophil elastase and cathepsin G.

J Immunol 2004 Jan;172(1):540-9

Unité de Défense Innée et Inflammation, Institut National de la Santé et de la Recherche Médicale, Equipe 336, Institut Pasteur, 25 rue du Dr. Roux, F-75724 Paris cedex 15, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.172.1.540DOI Listing
January 2004

Urokinase-type plasminogen activator (uPA) and its receptor (uPAR): development of antagonists of uPA/uPAR interaction and their effects in vitro and in vivo.

Curr Pharm Des 2003 ;9(19):1529-43

Klinische Forschergruppe der Frauenklinik, Technische Universität München, Ismaninger Str. 22, D-81675 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612033454612DOI Listing
September 2003

Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.

Biol Chem 2003 Aug;384(8):1119-31

Klinische Forschergruppe, Frauenklinik der Technischen Universität München, Klinikum rechts der Isar, D-81675 München, Germany.

View Article

Download full-text PDF

Source
https://www.degruyter.com/view/j/bchm.2003.384.issue-8/bc.20
Publisher Site
http://dx.doi.org/10.1515/BC.2003.125DOI Listing
August 2003

Novel bi- and trifunctional inhibitors of tumor-associated proteolytic systems.

Biol Chem 2003 Jul;384(7):1085-96

Klinische Forschergruppe der Frauenklinik der Technischen Universität München, Klinikum rechts der Isar, D-81675 München, Germany.

View Article

Download full-text PDF

Source
https://www.degruyter.com/view/j/bchm.2003.384.issue-7/bc.20
Publisher Site
http://dx.doi.org/10.1515/BC.2003.121DOI Listing
July 2003

Inhibition of intraperitoneal tumor growth of human ovarian cancer cells by bi- and trifunctional inhibitors of tumor-associated proteolytic systems.

Biol Chem 2003 Jul;384(7):1097-102

Klinische Forschergruppe der Frauenklinik, Technische Universität München, Klinikum rechts der Isar, D-81675 München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/BC.2003.122DOI Listing
July 2003